设为首页 加入收藏

TOP

Zometa 4 mg/100 ml solution for infusionZoledronic acid(六)
2013-07-10 01:07:07 来源: 作者: 【 】 浏览:10012次 评论:0
se reactions

The following adverse reactions, listed in Table 2, have been accumulated from clinical studies and post-marketing reports following predominantly chronic treatment with 4 mg zoledronic acid:


Table 2

Adverse reactions are ranked under headings of frequency, the most frequent first, using the following convention: Very common (1/10), common (1/100 to <1/10), uncommon (1/1,000 to <1/100), rare (1/10,000 to <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data).


Blood and lymphatic system disorders
 
  Common:
 Anaemia
 
  Uncommon:
 Thrombocytopenia, leukopenia
 
  Rare:
 Pancytopenia
 
Immune system disorders
 
  Uncommon:
 Hypersensitivity reaction
 
  Rare:
 Angioneurotic oedema
 
Psychiatric disorders
 
  Uncommon:
 Anxiety, sleep disturbance
 
  Rare:
 Confusion
 
Nervous system disorders
 
  Common:
 Headache
 
  Uncommon:
 Dizziness, paraesthesia, taste disturbance, hypoaesthesia, hyperaesthesia, tremor, somnolence
 
Eye disorders
 
  Common:
 Conjunctivitis
 
  Uncommon:
 Blurred vision, scleritis and orbital inflammation
 
  Very rare:
 Uveitis, episcleritis
 
Cardiac disorders
 
  Uncommon:
 Hypertension, hypotension, atrial fibrillation, hypotension leading to syncope or circulatory collapse
 
  Rare:
 Bradycardia
 
Respiratory, thoracic and mediastinal disorders
 
  Uncommon:
 Dyspnoea, cough, bronchoconstriction
 
Gastrointestinal disorders
 
  Common:
 Nausea, vomiting, anorexia
 
  Uncommon:
 Diarrhoea, constipation, abdominal pain, dyspepsia, stomatitis, dry mouth
 
Skin and subcutaneous tissue disorders
 
  Uncommon:
 Pruritus, rash (including erythematous and macular rash), increased sweating
 
Musculoskeletal and connective tissue disorders
 
  Common:
 Bone pain, myalgia, arthralgia, generalised pain
 
  Uncommon:
 Muscle cramps, osteonecrosis of the jaw*
 
Renal and urinary disorders
 
  Common:
 Renal impairment
 
  Uncommon:
 Acute renal failure, haematuria, proteinuria
 
General disorders and administration site conditions
 
 
 Common:
 Fever, flu-like syndrome (including fatigue, rigors, malaise and flushing)
 
 
 Uncommon:
 Asthenia, peripheral oedema, injection site reactions (including pain, irritation, swelling, induration), chest pain, weight increase, anaphylactic reaction/shock, urticaria
 
Investigations
 
 
 Very common:
 Hypophosphataemia
 
 
 Common:
 Blood creatinine and blood urea increased, hypocalcaemia
 
 
 Uncommon:
 Hypomagnesaemia, hypokalaemi

以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 3 4 5 6 7 8 9 下一页 尾页 6/15/15
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇Zometa 4 mg/5 ml concentrate fo.. 下一篇ADVAGRAF Cáps. dura de liberac..

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位